findmyKOL

Gonzalo Bearman, MD

Basic profile

Virginia Commonwealth University

ORCIDNPI
RegionRichmond, VA · SoutheastSpecialtyInfectious DiseaseFocusInfectious Disease
Last active 2024findmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2024Online presenceNot yet checkedPaymentsNone reportedNIH fundingNot yet indexedWhy? →

Gonzalo Bearman is an Infectious Disease physician affiliated with Virginia Commonwealth University. OpenAlex indexes 369 publications with 5,260 citations (h-index 40); ClinicalTrials.gov lists 2 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
369publications

Distinct works indexed by OpenAlex, matched via ORCID.

5,260citations

Total citations across indexed works.

40h-index

Hirsch index, productivity × impact (OpenAlex).

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

1250 E Marshall St
Internal Medicine
Richmond, VA 232985051

Telephone

804-828-2121

Registry record last updated 11 Sept 2025.

View the NPPES registry record

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Anti-infectives

    83.1%
    Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor27.3%
    Tivicay45%Dovato29%Juluca27%
    Part D<11 patients
    Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor13.7%
    Pifeltro75%Efavirenz-Emtric-Tenofov Disop26%
    Part D<11 patients

    + 8 more classes in this area

  • Sensory organs

    5.2%
    Aminoglycoside Antibacterial5.2%
    Gentamicin Sulfate100%
    Part D<11 patients
  • Blood & clotting

    4.7%
    Salt solutions4.7%
    Sodium Chloride100%
    Part D<11 patients
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”